✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

WuXi Biologics (Cayman) Inc

Common Name
WuXi Biologics (Cayman)
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
12,552
Ticker
2269
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Wuxi Biologics (Cayman) Inc. is a major player in the biotechnology and medical research sector, specializing in providing comprehensive solutions for the discovery, development, and manufacturing of ...

WuXi Biologics (Cayman)'s Financial Statements Preview

Below are the financial statements of WuXi Biologics (Cayman), including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of CNY
2024
2023
Revenue
18.68a
17.03a
Cost of sales
-11.02a
-10.21a
Gross profit
7.65a
6.83a
Other income
0.59a
0.42a
Impairment losses under expected credit loss model, net of reversal
-0.15a
-0.32a
Other gains and losses
-0.18a
0.04a
Selling and marketing expenses
-0.47a
-0.29a
Administrative expenses
-1.67a
-1.5a
Research and development expenses
-0.77a
-0.79a
Other expenses
0a
-0.05a
Financing costs
-0.16a
-0.16a
Profit before tax
4.83a
4.17a
Income tax expense
-0.89a
-0.6a
Profit for the year
3.95a
3.57a
Profit for the year attributable to
Owners of the company
3.36a
3.4a
Non-controlling interests
0.59a
0.17a
Limited Data Preview
You are viewing a limited preview of WuXi Biologics (Cayman)’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind WuXi Biologics (Cayman)’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore WuXi Biologics (Cayman)’s data sources below and access millions more through our Disclosure Search.

a. WuXi Biologics (Cayman)'s Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?